Latest Manufacturing News

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.

Microba Life Sciences reported a robust Q2 FY25 with revenue more than doubling year-on-year, driven by strong sales of its MetaXplore microbiome test in Australia and promising early adoption in the UK.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.

DroneShield Limited reports a 6.3% increase in 2024 revenue to $57.5 million, underpinned by a doubling of SaaS sales and a robust $1.2 billion sales pipeline heading into 2025.

MTM Critical Metals reports solid progress on its US-based Flash Joule Heating demonstration plant, targeting a Q4 2025 start-up in Texas amid favorable regulatory and funding prospects.

Sarytogan Graphite Limited has secured a key mining license and demonstrated promising product applications, supported by a significant investment from the European Bank for Reconstruction and Development. The company is progressing towards customer qualification and offtake agreements while expanding exploration efforts.

Pilbara Minerals reported a 14% drop in spodumene concentrate production for December Quarter FY25 amid operational shifts, yet revenue rose 3% driven by higher prices. The company advances its P1000 Project and secures approval to acquire Latin Resources, signaling growth ambitions.

Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.

Argent Minerals has reported compelling high-grade gold, silver, copper, indium, lead, and zinc mineralisation at its Wood Gully Gossan Prospect near Kempfield, NSW, confirming significant polymetallic potential and setting the stage for expanded exploration.

Battery Age Minerals has nearly doubled its landholding at the Bleiberg Project in Austria, securing a strategic corridor rich in zinc and germanium. This expansion positions the company to address growing global supply concerns amid China's export restrictions.

Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.